National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
Contains
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

azacitidine  Patient Information
A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation. Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms:5-AC
5-azacytidine
azacytidine
ladakamycin
US brand names:Mylosar
Vidaza
Abbreviation:5-AZC
Code name:U-18496
Chemical structure name:4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov